vs
Side-by-side financial comparison of ACV Auctions Inc. (ACVA) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $183.6M, roughly 1.1× ACV Auctions Inc.). IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-14.7M).
ACV Auctions Inc.ACVAEarnings & Financial Report
ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
ACVA vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.6M | $207.8M |
| Net Profit | — | $119.2M |
| Gross Margin | — | — |
| Operating Margin | -9.7% | 52.2% |
| Net Margin | — | 57.4% |
| Revenue YoY | 15.1% | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | $-0.12 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.6M | — | ||
| Q3 25 | $199.6M | $207.8M | ||
| Q2 25 | $193.7M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | $159.5M | — | ||
| Q3 24 | $171.3M | $0 | ||
| Q2 24 | $160.6M | $0 | ||
| Q1 24 | $145.7M | $0 |
| Q4 25 | — | — | ||
| Q3 25 | $-24.5M | $119.2M | ||
| Q2 25 | $-7.3M | — | ||
| Q1 25 | $-14.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-16.0M | $-51.8M | ||
| Q2 24 | $-17.1M | $-52.8M | ||
| Q1 24 | $-20.5M | $-39.6M |
| Q4 25 | -9.7% | — | ||
| Q3 25 | -11.9% | 52.2% | ||
| Q2 25 | -3.7% | — | ||
| Q1 25 | -7.9% | — | ||
| Q4 24 | -16.2% | — | ||
| Q3 24 | -10.0% | — | ||
| Q2 24 | -11.6% | — | ||
| Q1 24 | -15.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | -12.3% | 57.4% | ||
| Q2 25 | -3.8% | — | ||
| Q1 25 | -8.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -9.4% | — | ||
| Q2 24 | -10.6% | — | ||
| Q1 24 | -14.1% | — |
| Q4 25 | $-0.12 | — | ||
| Q3 25 | $-0.14 | $1.33 | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $-0.09 | — | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.10 | $-0.60 | ||
| Q2 24 | $-0.10 | $-0.68 | ||
| Q1 24 | $-0.13 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $271.5M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $429.7M | $1.1B |
| Total Assets | $1.1B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $271.5M | — | ||
| Q3 25 | $265.3M | $786.9M | ||
| Q2 25 | $258.4M | — | ||
| Q1 25 | $291.9M | — | ||
| Q4 24 | $224.1M | — | ||
| Q3 24 | $252.5M | $920.0M | ||
| Q2 24 | $215.0M | $701.7M | ||
| Q1 24 | $209.8M | $698.8M |
| Q4 25 | $429.7M | — | ||
| Q3 25 | $434.4M | $1.1B | ||
| Q2 25 | $448.8M | — | ||
| Q1 25 | $439.6M | — | ||
| Q4 24 | $440.0M | — | ||
| Q3 24 | $456.2M | $1.2B | ||
| Q2 24 | $457.6M | $931.7M | ||
| Q1 24 | $458.3M | $935.3M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $984.1M | — | ||
| Q3 24 | $1.0B | $1.2B | ||
| Q2 24 | $1.0B | $973.7M | ||
| Q1 24 | $1.0B | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-12.4M | $142.2M |
| Free Cash FlowOCF − Capex | $-14.7M | $142.2M |
| FCF MarginFCF / Revenue | -8.0% | 68.4% |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $69.1M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-12.4M | — | ||
| Q3 25 | $10.3M | $142.2M | ||
| Q2 25 | $13.7M | — | ||
| Q1 25 | $66.6M | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $21.1M | $-49.2M | ||
| Q2 24 | $4.5M | $-32.9M | ||
| Q1 24 | $43.0M | $-43.8M |
| Q4 25 | $-14.7M | — | ||
| Q3 25 | $7.7M | $142.2M | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $65.3M | — | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $20.2M | $-49.7M | ||
| Q2 24 | $2.7M | $-33.9M | ||
| Q1 24 | $41.9M | $-45.1M |
| Q4 25 | -8.0% | — | ||
| Q3 25 | 3.8% | 68.4% | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 35.7% | — | ||
| Q4 24 | -2.5% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 28.8% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACVA
| Auction Marketplace Revenue | $77.6M | 42% |
| Other Marketplace Revenue | $72.4M | 39% |
| Customer Assurance | $24.1M | 13% |
| Data Services Revenue | $9.4M | 5% |
IDYA
Segment breakdown not available.
